[서울=뉴스핌] Reporter Seongbong Lim = The general subscription of SK Bioscience, one of the biggest IPO words in the first half of this year, will close on the 9th.
SK Bioscience’s general subscription is received from six securities companies, including ▲NH Investment & Securities ▲Korea Investment & Securities ▲Mirae Asset Daewoo ▲SK Securities ▲Samsung Securities ▲Hana Financial Investment, for two days from the same day to the 10th. It is also possible to make multiple subscriptions using multiple securities company accounts.
 |
| [사진=한국투자증권] |
The offering price is 65,000 won, which is the top of the desired range (band), and the offering amount is about 1,491.8 billion won. As a result of the demand forecasting for institutional investors conducted on the last 4-5 days, 96.04% (1406) of the institutions participating in the demand forecasting presented a price of 65,000 won or more, the top of the band.
The number of applications that institutional investors participated in the obligation to hold was counted as 59.92% of the total number. It is highly likely that the stock price will not fluctuate after listing with a large amount of mandatory holdings. Conversely, if the stock price is small, the volume of institutional stocks to realize profits can be largely released when the stock price surges.
Stocks allocated to general subscribers amount to 19.12500 to 2295,000 shares, which is 25 to 30% of the total public offering.
SK Bioscience is engaged in the development and consignment production of the Corona 19 vaccine. The vaccine candidate material developed by SK Bioscience is currently in clinical trials. Investors are also interested in producing vaccine candidates with global companies such as AstraZeneca and NovaVax.
According to the subscription system reorganized from this year, half of the amount allocated to the public offering is distributed equally to the subscribers regardless of the size of the margin. Accordingly, you can receive more than one week even if you subscribe only for the minimum subscription quantity of 10 weeks.
SK Bioscience’s general subscription is scheduled to be held from 10:00 am to 4:00 pm instead of 9:00 am. This is to prevent system errors due to connection overload.
An official at a securities company said, “As customers who want to open an account for the subscription to SK Biosciences public offering stocks, the branch office has been very busy from the previous day.” Said.